| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.0092 | 0.8 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | -0.0092 | 0.8 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.0078 | 0.8 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.8 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.0082 | 0.8 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | -0.0077 | 0.8 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.0085 | 0.8 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.0086 | 0.8 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0081 | 0.8 |